Keyphrases
Antiretroviral Therapy
100%
Immune Regulation
100%
Gut Microbiota Composition
100%
Diversity Regulation
100%
Systemic Immune Activation
66%
Inflammation
50%
People Living with HIV (PLHIV)
50%
Plaque
50%
Fungal Diversity
50%
Fungal Community
50%
Microbiome
33%
Saliva
33%
Oral Microbiota
33%
Chronic Inflammation
33%
Bacterial Community
33%
Oral Microbiome
33%
Chronic Inflammatory Diseases
33%
Lipopolysaccharide
33%
Immunological Markers
33%
Bacterial Diversity
33%
Inflammatory Phenotype
33%
Severe Periodontitis
33%
Intervention Targets
33%
HIV Patients
16%
Periodontitis
16%
Cellular Biomarkers
16%
HIV Infection
16%
Postmenopausal Women
16%
Immune Stimulation
16%
Gut Microbiota
16%
Targeted Intervention
16%
Microbial Diversity
16%
Comorbidity
16%
Microbiota
16%
Clinical Characteristics
16%
Oral Cavity
16%
Immune Dysregulation
16%
Chronic Immune Activation
16%
Inflammation Markers
16%
Immune Dysfunction
16%
Non-associated
16%
Community Composition
16%
Microbial Products
16%
Linear Mixed-effects Regression Model
16%
Cell Markers
16%
Inflammatory Conditions
16%
Feedback Loop
16%
Gut Bacteria
16%
Clinical Attachment Loss
16%
Internal Transcribed Spacer Sequence
16%
Early HIV Infection
16%
Characteristic Markers
16%
Soluble Biomarkers
16%
Soluble Markers
16%
Microbiome Community
16%
Immune System Dysfunction
16%
Differential Abundance Analysis
16%
T Cell Depletion
16%
Gastrointestinal
16%
16S Ribosomal RNA (16S rRNA)
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Immunoregulation
100%
Microbial Diversity
100%
Periodontitis
50%
Human Immunodeficiency Virus Infection
33%
Oral Microbiome
33%
Intestine Flora
33%
Mouth Flora
33%
Microbiome
33%
Gut Microbiome
16%
Systemic Inflammation
16%
Immune Dysregulation
16%
Immunostimulation
16%
Microflora
16%
Postmenopause
16%
Teeth
16%
T Cell
16%
Immune System
16%
Immune System Disorders
16%
Comorbidity
16%
Ribosomal RNA
16%
Ribosome RNA
16%